Author:
Wada H.,Okamoto K.,Iba T.,Kushimoto S.,Kawasugi K.,Gando S.,Madoiwa S.,Uchiyama T.,Mayumi T.,Seki Y.
Funder
Ministry of Health, Labour and Welfare of Japan for Blood Coagulation Abnormalities
Ministry of Education, Culture, Sports, Science and Technology of Japan
Reference9 articles.
1. Yoshioka A; Japanese Society of Thrombosis Hemostasis/DIC subcommittee: Expert consensus for the treatment of disseminated intravascular coagulation in Japan;Wada;Thromb Res,2010
2. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial;Saito;J Thromb Haemost,2007
3. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation;Mimuro;Thromb Res,2013
4. A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation;Vincent;Crit Care Med,2013
5. Isolation of a membrane-bound cofactor for thrombin- catalyzed activation of protein C;Esmon;J Biol Chem,1982
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献